Suppr超能文献

家庭肠外营养的生存情况及依赖程度:英国一家转诊中心25年的经验

Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre.

作者信息

Lloyd D A J, Vega R, Bassett P, Forbes A, Gabe S M

机构信息

Lennard-Jones Intestinal Failure Unit, St Mark's Hospital and Academic Institute, Watford Road, Harrow, UK.

出版信息

Aliment Pharmacol Ther. 2006 Oct 15;24(8):1231-40. doi: 10.1111/j.1365-2036.2006.03106.x.

Abstract

BACKGROUND

Home parenteral nutrition (HPN) is the standard treatment for severe intestinal failure in the United Kingdom.

AIM

To review long-term survival and ongoing HPN dependence of patients receiving HPN treated at a specialist UK referral centre.

METHODS

Medical records of patients commenced on HPN between 1979 and 2003 were reviewed retrospectively. Regression analysis was employed to identify factors associated with poor prognosis.

RESULTS

Case notes of 188 patients were reviewed. Overall probability of survival was 86%, 77%, 73% and 71% at 1, 3, 5 and 10 years after starting treatment. In multivariate analysis, association was seen between mechanism of intestinal failure and survival: short bowel syndrome associated with a favourable prognosis, and intestinal dysfunction, dysmotility and obstruction with poorer prognoses. There was an association between increasing age and poor prognosis, but increased mortality was also seen in the youngest age groups. Only 9% of deaths were due to complications of HPN. Continued HPN dependence was 89%, 87%, 84% and 84% at 1, 3, 5 and 10 years in survivors.

CONCLUSIONS

Long-term survival of patients receiving HPN remains better than that reported after intestinal transplantation. Mortality predominantly relates to underlying disease rather than complications of HPN.

摘要

背景

在英国,家庭肠内营养(HPN)是严重肠衰竭的标准治疗方法。

目的

回顾在英国一家专科转诊中心接受HPN治疗的患者的长期生存率及持续依赖HPN的情况。

方法

对1979年至2003年间开始接受HPN治疗的患者的病历进行回顾性分析。采用回归分析确定与预后不良相关的因素。

结果

对188例患者的病历进行了回顾。开始治疗后1年、3年、5年和10年的总体生存率分别为86%、77%、73%和71%。多因素分析显示,肠衰竭机制与生存率之间存在关联:短肠综合征预后良好,而肠功能障碍、动力障碍和梗阻预后较差。年龄增加与预后不良相关,但最年轻年龄组的死亡率也有所增加。仅9%的死亡是由HPN并发症所致。存活患者在1年、3年、5年和10年时持续依赖HPN的比例分别为89%、87%、84%和84%。

结论

接受HPN治疗的患者的长期生存率仍高于肠移植后的报道。死亡率主要与基础疾病有关,而非HPN并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验